Henry Hess | CLC |
Reenie McCarthy | CEO |
Rob Weiskopf | CFO |
Jim Carr | CCDO |
Brian Blakey | CCO |
Charles Duncan | Cantor Fitzgerald |
Yi Chen | H.C. Wainwright |
Greetings, and welcome to the Stealth BioTherapeutics Third Quarter 2020 Financial Results and Recent Business Highlights. [Operator Instructions] A brief question and answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introduce your host, Henry Hess. Thank you, Henry.
You may begin.